Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 10;15(8):e0237404. doi: 10.1371/journal.pone.0237404

Pulmonary function analysis in cotton rats after respiratory syncytial virus infection

Margaret E Martinez 1,*, Olivia E Harder 1, Lucia E Rosas 1, Lisa Joseph 1, Ian C Davis 1, Stefan Niewiesk 1
Editor: Steven M Varga2
PMCID: PMC7416943  PMID: 32776985

Abstract

The cotton rat (Sigmodon hispidus) is an excellent small animal model for human respiratory viral infections such as human respiratory syncytial virus (RSV) and human metapneumovirus (HMPV). These respiratory viral infections, as well as other pulmonary inflammatory diseases such as asthma, are associated with lung mechanic disturbances. So far, the pathophysiological effects of viral infection and allergy on cotton rat lungs have not been measured, although this information might be an important tool to determine the efficacy of vaccine and drug candidates. To characterize pulmonary function in the cotton rat, we established forced oscillation technique in uninfected, RSV infected and HDM sensitized cotton rats, and characterized pulmonary inflammation, mucus production, pulmonary edema, and oxygenation. There was a gender difference after RSV infection, with females demonstrating airway hyper-responsiveness while males did not. Female cotton rats 2dpi had a mild increase in pulmonary edema (wet: dry weight ratios). At day 4 post infection, female cotton rats demonstrated mild pulmonary inflammation, no increase in mucus production or reduction in oxygenation. Pulmonary function was not significantly impaired after RSV infection. In contrast, cotton rats sensitized to HDM demonstrated airway hyper-responsiveness with a significant increase in pulmonary inflammation, increase in baseline tissue damping, and a decrease in baseline pulmonary compliance. In summary, we established baseline data for forced oscillation technique and other respiratory measures in the cotton rat and used it to analyze respiratory diseases in cotton rats.

Introduction

Respiratory syncytial virus (RSV) infection of infants and children younger than 5 years of age causes an estimated 200,000 fatalities worldwide each year [1]. Hospitalization is often due to severe bronchiolitis and obstructive airway disease that is attributed to bronchiolar (small airway) inflammation, edema, necrosis and intraluminal plugs comprised of sloughed necrotic epithelium, mucus, and inflammatory cells [2, 3]. Ultimately, the clinical manifestation of hospitalized infants from RSV infection is decreased pulmonary compliance, increased airway resistance, wheezing and hypoxemia with a mean arterial oxygen saturation (SaO2) of 85% [2, 4, 5]. RSV bronchiolitis in infants has also been associated with recurrent wheezing, asthma, and pulmonary dysfunction such as airway hyper-responsiveness (AHR) later in childhood [2, 6]. However, there are disagreements in the literature on whether abnormal lung function predisposes infants to RSV infection or whether RSV infection causes abnormal lung function [5, 7].

In order to understand the pathophysiology of RSV infection, many laboratories have investigated the effects of RSV on the mouse lung with inconsistent results. A few studies reported baseline respiratory perturbations after RSV infection [810], while several others did not [1122]. Some studies concluded that RSV in mice is associated with AHR during acute infection [10, 14, 1619, 23, 24], particularly after re-infection or with confounding conditions like lung injury or allergen sensitization [1115, 17, 2022, 25]. However, other studies did not find a correlation between AHR and RSV infection [11, 12, 2022, 2426]. A contributing factor to divergent results might be the use of plethysmography or breath distention techniques which have a relatively low sensitivity [811, 14, 15, 17, 1921, 2325, 2729]. Another confounding factor might be that mice are not an ideal model for RSV infection as they require a supraphysiologic inoculum for infection and the virus replicates poorly in the lung and does not replicate in the nasal epithelium [30, 31]

In contrast to the mouse, the cotton rat is susceptible to upper and lower respiratory tract infections with RSV, and requires a lower inoculum similar to that seen in infants for infection [31, 32]. In this study, we attempted to characterize pulmonary function in cotton rats after RSV infection using the most sensitive techniques available. We established a protocol for cotton rats which allowed us to use forced oscillation technique, via the flexiVent system, to accurately define the effects of asthma and RSV on lung mechanics (e.g. resistance and compliance) [28, 33, 34]. In addition, we measured arterial blood gases during infection to accurately quantify the clinical perturbations of lung function [35]. Furthermore, we quantified the impact of RSV on airway mucus production using a precise color deconvolution algorithm [9] and compare RSV infection with allergy sensitization after house dust mite antigen (HDM) injection.

Material and methods

Cotton rats

Inbred cotton rats (Sigmodon hispidus) were housed in polysulfone microisolation cages (NextGen Rat 900, Allentown Inc., Allentown, NJ, USA) in a barrier facility with a 12:12 h light cycle. Cotton rats were maintained in an environment with a temperature of 20 ± 2°C and 30% to 70% relative humidity. Cotton rats were 6–8 weeks of age. All studies were approved by The Ohio State University Institutional Animal Care and Use Committee.

Viruses

Stocks of RSV A2 and RSV line 19F were grown in human epithelial type 2 (HEp2) cells in MEM supplemented with 2% fetal calf serum as previously described [36]. Viruses were sucrose purified and titered on HEp2 cells.

RSV infection

Animals were sedated with isoflurane administered in a chamber and subsequently inoculated intranasally (IN) with 100μl virus (1x105 TCID50).

Lung fixation and histologic examination of inflammation and mucus production

Cotton rats were euthanized by carbon dioxide inhalation. The lungs were inflated with 1mL of 4% paraformaldehyde (PFA) and fixed in 4% PFA. All tissues were routinely processed, embedded in paraffin wax, and sectioned (4μm) according to the revised guide for organ sampling and trimming in rats and mice by the European Experimental and Toxicologic Pathology group [37].

Cotton rat lung histology slides were stained routinely with hematoxylin and eosin (H&E). Light microscopic evaluation was performed by a veterinary anatomic pathologist (MM) (model CX41, Olympus, B and B Microscopes Limited, Pittsburgh, PA, USA). A semi-quantitative scoring system, adapted from previous studies [9] was used (S1 Table). The sum of the mean scores were calculated to produce a total histologic inflammatory score.

For detection of mucus production, cotton rat lung histology slides were stained with Periodic acid-Schiff (PAS) and Alcian Blue. Whole slide images were scanned at 40x magnification (ScanScope XT, Aperio Technologies). Similar to previous studies, quantification of mucus staining was performed using the Color Deconvolution algorithm available in the Image Analysis Toolbox (Aperio Technologies) [9, 13]. The total percent positive staining cells, percent strong positive staining, and average strong staining intensity were calculated and compared between groups. A histologic semi-quantitative scoring system based on the percentage of PAS positive bronchiolar cells present was applied (S2 Table).

Broncho-alveolar lavage

Broncho-alveolar lavage fluid (BALF) was collected as previously described [36]. BALF was collected from cotton rats immediately after euthanasia. The trachea was cannulated, and the lungs were lavaged with 1mL of PBS supplemented with 1% protease-free BSA. The BALF was kept on ice until processed (Comparative Pathology and Mouse Phenotyping Shared Resource, Ohio State University). Automated nucleated cell counts were performed by using a Forcyte veterinary hematology analyzer (Oxford Science, Oxford, United Kingdom).

Lung wet: Dry weight ratio

Lung wet: dry weight ratio was measured as previously described [38, 39]. Rats were euthanized and their lungs were removed, weighed, and dried in an oven at 55°C for 48 hours. After drying, lungs were weighed again. Wet: dry weight ratio was then calculated as an index of intrapulmonary fluid accumulation, without correction for blood content.

Pulse oximetry measurements

The medial thighs and ventral neck were clipped 48 hours before measurements were taken. Cotton rats were sedated by inhaled isoflurane initially in a chamber, and then maintained with a nose cone on room air (FiO2 = 0.21). Peripheral capillary oxygen saturation (SpO2), heart rate, pulse distention, and breath rate were measured with the collar clip sensor (Starr Life Sciences Corp., Allison Park, PA, USA) in accordance with manufacturer’s instructions. The same parameters as well as breath distention were measured with the thigh clip sensor. Data were collected for a minimum of 10 seconds (150 data points) per animal [39].

Measurement of arterial blood gases

Cotton rats were anesthetized as for flexiVent studies, tracheotomized, and mechanically ventilated on room air (FiO2 = 0.21). No other lung function tests were performed before or after blood collection, as this was a terminal procedure. The carotid artery was isolated and ligated cranially in order for 200μL of blood to be collected in a heparinized 1mL syringe. pHa, PaCO2, and PaO2 were measured using ab EG6+ cartridge in an iSTAT® blood gas analyzer (Abbott Laboratories, Abbott Park, IL, USA). The P/F ratios were calculated by dividing the arterial partial pressure (PaO2) by the fraction of inspired oxygen (FiO2), which on room air is 0.21.

House dust mite (HDM) antigen sensitization

100μg house dust mite (HDM, Dermatophagoides pteronyssinus) antigen was absorbed in aluminum phosphate (AdjuPhos, Brenntag, Ballerup, Denmark) at 1:1 ratio for 30 minutes at room temperature. HDM was administered intraperitoneally (IP). Sensitization was followed 8 days later with intranasal (IN) administration of 100μg HDM in a volume of 100μL PBS. Four days after IN HDM administration, cotton rats were anesthetized and forced oscillation technique was performed or lungs were collected for histologic examination.

Anesthesia and tracheotomy protocols

Cotton rats were first sedated with isoflurane administered in a chamber for 7 minutes. Rats were next administered 10mg/kg diazepam IP, followed by 100mg/kg ketamine IP 7 minutes later. A surgical plane of anesthesia was determined by the lack of a response to interdigital forceps grasp. If a surgical plane was not achieved within 15 minutes of ketamine dosage, an additional half dose of ketamine was administered.

Seventy percent ethanol was applied to the ventral neck, and the ventral neck skin was excised. The salivary glands were bluntly separated and placed laterally, and the sternohyoid and sternothyroid muscles were removed exposing the trachea. A scalpel was used to incise the trachea between the first and second tracheal rings, and a 4cm 15 gauge gastric tube (cat. 724446, Harvard Apparatus, Holliston, MA, USA) was placed as the tracheal cannula. A circumferential suture was tightened around the exterior of the trachea.

Forced oscillation technique

Mechanical properties of the cotton rat lung were assessed using forced oscillation technique, which is a terminal procedure. Anesthesia and tracheotomy were performed as described above. Rocuronium was administered (10mg/mL IP), and the rat was ventilated on a computer-controlled piston ventilator (flexiVent, SCIREQ, Montreal, Quebec, Canada) with a tidal volume of 10mL/kg at a frequency of 90 or 150 breaths/minute against 3cmH2O positive end-expiratory pressure (PEEP). Both the flexiVent Module 2 (4.8mL stroke FV-M2) and the FX module 3 were used with the previous settings. Following two total lung capacity (TLC) maneuvers, pressure and flow were collected during a series of standardized volume perturbation maneuvers. Total lung resistance (R) and elastance (E) were calculated using the single-compartment model and used to derive further parameters of respiratory function: RN (Newtonian resistance, composed mostly of the flow resistance of the conducting pulmonary airways), G (tissue damping, reflective of resistance of peripheral airways and parenchyma), and H (parenchymal tissue elastance). The flexiVent calibration procedure removes cannula impedance from the reported data. Residual inertance (I) is therefore negligible and is not reported herein [26, 40]. If the cannula contained fluid on extubation or the subject died before completion of the lung function measurements, then that subject was excluded from the study.

Methacholine challenge

Following baseline recordings of lung-function parameters with saline-only nebulization, airway hyper-responsiveness was assessed on the flexiVent exposed to increasing doses of methacholine (0.1, 1.0, 10.0, 20.0, and 50.0 mg/ml) in sterile normal saline prepared fresh daily. Each methacholine dose was delivered over a 10 second period via an AeroNeb vibrating plate ultrasonic nebulizer, in series with the inspiratory limb of the flexiVent Y-tube. Ten recordings of R and E were generated following administration of each methacholine dose, and mean values of all 10 measurements for each parameter at each methacholine dose were thereby obtained [26, 40].

Statistics

Statistics were performed using GraphPad Prism Software version 6.07 (San Diego, CA, USA). Differences between groups were analyzed using a One-Way ANOVA or unpaired two-tailed student T test, with Tukey’s multiple comparison posttests. P < 0.05 was considered statistically significant. Individual experiments were repeated 3 to 5 times. Aggregate animal numbers were statistically analyzed. Males and females were used for each parameter measured and compared to each other to determine the effect of gender. All data are represented as means +/- standard deviations with individual data points.

Results

RSV infection causes a mild increase in pulmonary inflammation but not an increase in mucus production

In order to evaluate lung pathophysiology of cotton rats after RSV infection, we assessed histology, mucus production, tissue edema, blood oxygenation and lung mechanics. The first step of the study was the characterization of the inflammatory response to RSV in the cotton rat lung so that the histologic findings could be compared to the lung function analysis and to allergen sensitization with house dust mite (HDM) antigen [15, 36]. Lungs were assessed histologically for inflammation based on the number of peribronchiolar, perivascular, bronchiolar, interstitial and alveolar inflammatory infiltrates and assigned a score of 0–4 based on a scoring scheme as described in S1 Table [9]. After RSV infection, peak titers of viral replication are observed on day 4 and 5, with a virus-specific immune response being detectable on day 5. Consistent with these findings was the moderate increase in inflammatory infiltrates 4 and 5 days post-infection (DPI) with RSV A2 (Fig 1A) with a mean histologic inflammatory score on day 4 of 4.3 +/- 1.9 and on day 5 of 5.3 +/- 0.9 (out of 30). This correlated with a low number of white blood cells obtained by broncho-alveolar lavage (BAL) (Fig 1B). The type and location of inflammatory infiltrates was similar between 4 and 5 days post-RSV infection (Fig 1C). HDM-sensitized cotton rats demonstrated a statistically significant higher histologic inflammatory score of 13.2 +/- 1.2 (Fig 1A) which correlated well with the number of cells within fluid obtained by broncho-alveolar lavage (BALF). Uninfected cotton rats had an average white blood cell count (WBC) of 444 +/- 113.5/ul, while 5 DPI RSV cotton rats had a mean WBC/ μL in BALF of 405 +/- 112, and HDM sensitized cotton rats had a mean WBC/ μL in BALF of 1025 +/- 188.

Fig 1. Inflammation after RSV A2 infection.

Fig 1

1a. The semi-quantitative scoring of inflammation in lung sections of uninfected cotton rats, cotton rats 5 and 4 days post-RSV infection, and HDM-sensitized cotton rats was compared. The mean and standard deviations are represented (n = 4/ group). Asterisks indicate a p value < 0.05 by One-Way ANOVA. 1b. The total white blood cells per μL of bronchoalveolar lavage fluid (WBC/BALF) were compared between uninfected cotton rats, 5 days post-RSV infected cotton rats, or HDM sensitized cotton rats. Individual points represent the mean WBC/BALF from one animal with the mean and standard deviations represented too; 19DPI AAV-GFP (n = 3), 19DPI AAV-G (n = 3), 5DPI RSV (n = 4). Astericks indicate a p value < 0.05 by One-Way ANOVA. 1c. An H&E stain of an uninfected cotton rat lung representative of no to minimal inflammation. 1d. An H&E stain of a 4dpiRSV cotton rat lung representative of mild inflammation characterized by small numbers of peribronchiolar and perivascular lymphocytes and histiocytes. 1e. An H&E stain of a HDM sensitized cotton rat lung representative of moderate inflammation characterized by many peribronchiolar and perivascular lymphocytes and histiocytes, and numerous granulocytes within alveolar septae (interstitial infiltrates), abundant macrophages and granulocytes within alveoli, and many granulocytes within bronchiolar epithelium.

Mucus production after RSV infection

The strong mucus production observed in infants after infection with RSV can lead to disturbances in lung mechanics (increased baseline airway resistance). To obtain comparative data in cotton rats, we quantified bronchiolar mucus production after infection with two strains of RSV. Whereas RSV A2 is a commonly used laboratory strain, RSV line 19F is a recombinant RSV which expresses a fusion protein associated with increased (two-fold from a very low background) mucus production in the mouse [8, 16, 41]. Infection with both strains was evaluated for induction of mucus in the cotton rat, as previous mouse studies have suggested that RSV line 19F induces more mucus production than RSV A2 [16]. In tissue sections stained for mucus with Periodic acid-Schiff and Alcian blue, an average of 101 bronchioles per slide were analyzed using the color deconvolution algorithm in the Image Analysis Toolbox. The percentage of positive mucus staining (Fig 2), the percentage of strong positive mucus staining, and the average staining intensity were quantified. There were no significant differences in mucus staining of cells between uninfected, RSV A2 infected, and RSV line 19F infected cotton rats (Fig 2). In addition, there was no significant difference in the intensity of staining (mean percent of strong positive staining cells) or the overall mucus production (mean staining intensity) between groups. When mucus production was evaluated 5 days post-infection using a semi-quantitative scoring system (S2 Table), there was still no significant difference in mucus production between the RSV A2 infected and uninfected cotton rats (S1 Fig). Therefore, RSV does not induce increased mucus production in the cotton rat.

Fig 2. Mucus production in cotton rats 8 days post-infection with RSV A2 and RSV line 19F.

Fig 2

2a. Quantification of PAS and Alcian blue positive (mucus) staining in bronchioles was performed using the Color Deconvolution algorithm in Image Analysis Toolbox. Mucus production was assessed at 8dpi based on previous studies in the mouse [8, 16]. The mean total percent positive staining cells and standard deviations are represented (n = 5/ group). Asterisks indicate p value < 0.05 when compared to uninfected cotton rats by One-Way ANOVA. 2b. A representative airway and adjacent alveoli of a PAS/ Alcian blue stained section of uninfected cotton rat lung with little to no mucus production. 2c. A representative airway and adjacent alveoli of a PAS/ Alcian blue stained section of cotton rat lungs 8dpi RSV A2 infection with little to no mucus production. 2d. A representative airway and adjacent alveoli of a PAS/ Alcian blue stained section of cotton rat lungs 8dpi RSV line 19F infection with little to no mucus production.

Increase in pulmonary edema has no effect on oxygenation

Another parameter of respiratory function is the development of pulmonary edema which decreases pulmonary compliance. The quantification of cotton rat lungs after RSV infection demonstrated a small but significant increase in the lung wet: dry weight ratios at 2 days post-infection with RSV compared to uninfected cotton rats (Fig 3). When only female cotton rats with corresponding lung function data were evaluated, there was no significant difference in pulmonary edema between the groups (S2 Fig).

Fig 3. Pulmonary edema after RSV A2 infection.

Fig 3

The lung wet: dry weigh ratios in uninfected cotton rats and cotton rats 2, 4 or 6 days post-RSV infection. Mean wet: dry weight ratios and standard deviations are represented. Asterisks indicate p value < 0.05 when compared to uninfected cotton rats by One-Way ANOVA; uninfected (n = 22), 2DPI RSV (n = 20), 4DPI RSV (n = 20), 6 DPI RSV (n = 8).

To determine whether the increase in wet: dry weight ratios at day 2 post-infection altered gas exchange, we performed pulse oximetry to measure carotid and femoral oxygen saturation, heart rate, breath rate and breath distention. Collar sensor clips were applied to the clipped ventral necks over the carotid arteries. Thigh clips were applied to clipped medial thighs over the femoral artery. The thigh clip sensor also measured breath distention. Those parameters for uninfected cotton rats as well as cotton rats 2, 4, and 6 days post-RSV infection are in S3 and S4 Tables. The average peripheral oxygen saturation in uninfected cotton rats was 99.05% +/- 0.4, with an average heart rate of 525 +/- 18.5 beats per minute. On day 4 post-RSV infection, cotton rats did not have significantly higher mean heart rates and breath rates using femoral artery measurements. There was also no significant differences between SpO2, heart rate, and breath rate when the two clip locations were compared to each other. The only statistically significant difference was between the collar clip and thigh clip was pulse distention. This difference is expected and represents the variations in hydrostatic pressures between the carotid and femoral artery based on proximity to the heart.

Since oxygen saturations are a relatively insensitive measure of alveolar gas exchange, we also measured arterial blood gases from blood drawn from the carotid artery (S5 Table). Uninfected cotton rats had mean PaO2 values of 143 +/- 39, PaCO2 values of 26 +/- 9, pHa of 7.3 +/- 0.2, and P/F ratio of 679 +/- 186. Though day 2 and 4 RSV infected cotton rats had a lower mean PaO2 and P/F ratio, and higher PaCO2, all arterial blood gas parameters for the groups were not significantly different. In conclusion, there was no significant difference in blood oxygenation in cotton rats after RSV infection.

Measuring lung function with forced oscillation technique in uninfected cotton rats

An increase in baseline airway resistance and decrease in pulmonary compliance has been documented in RSV hospitalized infants and children [5]. RSV infection is also associated with recurrent wheezing, asthma, and pulmonary dysfunction such as airway hyper-responsiveness (AHR) later in childhood [2, 6]. AHR is defined as the exaggerated narrowing of airways to a stimulus that does not result in comparable airway narrowing in healthy subjects [4244]. In normal physiologic airway constriction, the stimulus for bronchoconstriction is acetylcholine, which is released from peribronchiolar nerves. Therefore, AHR is assessed experimentally by comparing resistance between uninfected and infected subjects after stimulation with nebulized methacholine, an acetylcholine agonist.

The forced oscillation technique (FOT) is the preferred method for measuring lung function in children [28, 33, 34, 42] as it allows detailed and comprehensive assessment of lung mechanics. The most pertinent measurements are baseline and peak total airway resistance, baseline and peak tissue damping, and baseline pulmonary compliance as these are the lung function parameters that have been demonstrated to be altered in infected infants and children [5, 7]. FOT consists of applying an oscillatory waveform to a subject and measuring the pressure, flow, and volume responses to measure total airway resistance (R), pulmonary compliance (C), Newtonian resistance (large/ central airway resistance), tissue damping (G, peripheral/ small airway and alveolar resistance), and tissue elastance (alveolar elasticity/ the reciprocal of compliance). With these parameters, AHR is measured through increasing dosages of methacholine up to 50mg/mL.

In order to compare the effects of RSV infection on lung mechanics in cotton rats, we established reference data for uninfected animals using the FV-M2 flexiVent system (Fig 4). Uninfected male cotton rats a mean baseline airway resistance (Rb) of 0.22cmH2O.s/mL +/- 0.014, and following exposure to 50mg/mL methacholine had mean airway resistance (Rmax) increased to 0.63cmH2O.s/mL +/- 0.16 (191.5% change from baseline +/- 85). Uninfected female cotton rats had a mean Rb of 0.22cmH2O.s/mL +/- 0.018, and a mean Rmax of 0.72cmH2O.s/mL +/- 0.13 (226.7% change from baseline +/- 55). Our data demonstrated that the cotton rat does respond to methacholine exposure in an expected exponential fashion. There is an initial exponential increase in airway resistance after methacholine exposure, with eventual plateauing of airway resistance at higher dosages due to a presumed saturation of muscarinic receptors in the peribronchiolar smooth muscles.

Fig 4. Influence of gender on lung mechanics in uninfected and 4 days post-RSV A2 infection.

Fig 4

The mean and standard deviation for each group are represented. Fig a-b represent total airway resistance (R). Fig c-d represent tissue damping (G). Fig e-f represent dynamic pulmonary compliance (C). Fig a, c, and e represent the baseline measurements for R, G, and C. Fig b, d, and f represent the measurements obtained at 50mg/mL methacholine dosage for R, G, and C. Bars indicate p< 0.05 by One-way ANOVA; male uninfected (n = 5), female uninfected (n ranges 7–6), male 4DPI RSV (n ranges 4–3), female 4DPI RSV (n ranges 7–6).

Female, and not male, cotton rats demonstrated perturbations in respiratory function measurements at 4 days after RSV infection

Several pulmonary function studies analyze respiration perturbations using only one gender [24, 26, 43]; however, one study found that there are gender differences to lipopolysaccharide induced AHR [44]. In patients, male children have a higher incidence and disease severity associated with RSV infection than female children [45]. Therefore, we analyzed the differences in airway resistance, tissue damping and pulmonary compliance in RSV infected female and male cotton rats. We compared pulmonary function at 4 days post-RSV infection since this is the time point in which there is peak viral replication in the lungs of cotton rats [46].

Four days after RSV infection male cotton rats had an Rb of 0.25cmH2O.s/mL +/- 0.034, and a mean Rmax of 0.55cmH2O.s/mL +/- 0.13 (126.3% change from baseline +/- 71). Four days after RSV infection, female cotton rats had a mean Rb of 0.26cmH2O.s/mL +/- 0.029, and Rmax of 0.9326cmH2O.s/mL +/- 0.19 (259% change from baseline +/- 73). There was a significant difference in Rb and Cb between uninfected and 4 days post-RSV infected female cotton rats, which was not seen in males (4A and 4E). There was also a significant difference between the Rmax (p = 0.0314) and Gmax (p = 0.0033) values of male and female 4 days post-RSV infected rats (Fig 4B and 4D). The Rmax values of 4DPI RSV infected male cotton rats were directly compared to uninfected male cotton rats using an unpaired two tailed student t-test, as well as 4DPI RSV infected female cotton rats to uninfected female cotton rats. There was a significant difference in Rmax between 4DPI RSV and uninfected female cotton rats (p = 0.0314), though not in 4DPI RSV and uninfected male cotton rats (p = 0.417). Similarly, there was a significant difference in Gb when 4DPI RSV infected female cotton rats were compared to uninfected females using an unpaired two tailed student t-test (p = 0.0217). Therefore, when directly compared to their respective gendered uninfected rats, female cotton rats demonstrated AHR 4 days post-RSV infection while male cotton rats did not.

One possibility for the putative difference in lung function between the genders was a difference in airway lumen. Therefore, the mean airway luminal diameter of female and male cotton rats was measured using histologic sections. The mean airway diameter in male cotton rats was 155μm (+/- 25) and the mean diameter in females was 138μm (+/- 4), which were not significantly different from each other (S3 Fig). Also, there was no significant difference between uninfected male and female Rb and Gb to indicate one gender’s airways being smaller than another (Fig 4A and 4C). Thus, it was determined that greater lung function disturbances observed in RSV infected female cotton rats were not due to a difference in airway morphology.

RSV infection in cotton rats does not cause clinically significant respiratory dysfunction

To further evaluate lung function, cotton rats were intranasally infected with RSV and lung mechanics were measured on day 2, 4, 6, and 28 post-infection (Fig 5 and S4 Fig). When both genders and all time-points were compared, Cb was significantly lower in 4DPI RSV cotton rats than uninfected cotton rats (S5 Fig). Similarly when females were analyzed separately without the male data, Cb remained significantly lower at 4DPI RSV compared to uninfected (Fig 5E). The decrease in baseline compliance represents stiffer pulmonary parenchyma, which is an expected lung function disturbance in infants infected with RSV [5]. However, there was no significant difference in any other baseline parameters measured in any group compared to uninfected cotton rats (Fig 5A and 5C) as would also be expected to be different as seen in infected infants [5, 6, 47]. Lastly, there was also no evidence of AHR (Fig 5B and 5D). The lack of difference between these results comparing multiple groups versus comparing infected with uninfected cotton rats in the previous experiment might be due to the fact that biological differences have to be larger to be significant in multi-group comparisons or is due to instrumental sensitivity.

Fig 5. Lung mechanics in uninfected cotton rats and 2, 4, 6 and 28 days post-RSV A2 infection female cotton rats.

Fig 5

The mean and standard deviation for each group are represented. Fig a-b represent total airway resistance (R). Fig c-d represent tissue damping (G). Fig e-f represent dynamic pulmonary compliance (C). Fig a, c, and e represent the baseline measurements for R, G, and C. Fig b, d, and f represent the measurements obtained at 50mg/mL methacholine dosage for R, G, and C. Bars indicate p< 0.05 by One-way ANOVA; uninfected (n ranges 7–6), 2DPI RSV (n = 3), 4DPI RSV (n ranges 7–6), 6DPI RSV (n = 5), 28DPI RSV (n ranges 6–5).

In order to determine whether the observed differences were due to instrumentation or statistical analysis, we compared lung mechanics in female cotton rats 4 days post-infection using the latest most sophisticated FX3 flexiVent module (SCIREQ, Montreal, Quebec, Canada). There were no significant differences in any of the parameters evaluated between uninfected and 4 days post-RSV infected female cotton rats (S6 Fig). For most of the parameters measured, the FX3 flexiVent system had smaller standard deviations compared to the FV-M2 flexiVent system.

HDM sensitized female cotton rats demonstrate airway hyper-responsiveness, increased baseline tissue damping, and decreased pulmonary compliance

We applied our newly developed technology in cotton rats for the analysis of lung function to an allergy model (immunization with HDM). Cotton rats were sensitized with HDM and responses to increasing dosages of methacholine (0.1–50mg/mL) were measured (Fig 6; S7 Fig). HDM sensitization had no effect on Rb, with a mean of 0.26cmH2O.s/mL +/- 0.040 (Fig 6A). However, following exposure to 50mg/mL methacholine, uninfected female cotton rats had mean Rmax increase to 0.72cmH2O.s/mL +/- 0.13 (226.7% change from baseline +/- 55), whereas the mean Rmax of HDM sensitized rats was 1.15cmH2O.s/mL +/- 0.13 (353.4% change from baseline +/- 80). There was a significant difference between the two groups Rmax (unpaired student t-test, p = 0.0005), as expected and therefore, the HDM sensitized female cotton rats demonstrated AHR (Fig 6B). Furthermore, there was a significant difference in baseline tissue damping (Gb) (p = 0.0016) as well as the tissue damping at 50mg/mL methacholine dosage (Gmax) (p = 0.0002) between the two groups (Fig 6C and 6D). The difference in tissue damping supports the interpretation of AHR as well as localizing the airway hyper-responsiveness to the smaller airways. Although Rb was not different from uninfected rats, Gb was significantly higher in HDM sensitized rats indicating small airway obstruction (Fig 6C). There was also a significant difference (p<0.0001) in baseline pulmonary compliance (Cb) as well as compliance (Cmax) measured at 50mg/mL methacholine dosage (p = 0.277) in HDM sensitized cotton rats compared to uninfected female cotton rats (Fig 6E and 6F).

Fig 6. Lung mechanics in uninfected cotton rats and HDM-sensitized female cotton rats.

Fig 6

The mean and standard deviation for each group are represented. Fig a-b represent total airway resistance (R). Fig c-d represent tissue damping (G). Fig e-f represent dynamic pulmonary compliance (C). Fig a, c, and e represent the baseline measurements for R, G, and C. Fig b, d, and f represent the measurements obtained at 50mg/mL methacholine dosage for R, G, and C. Asterisks indicate p< 0.05 by two-tailed unpaired Student T-test; uninfected (n ranges 7–6), HDM (n = 4).

Discussion

This is the first report of forced oscillation technique (FOT) in the cotton rat, which allows for detailed and precise characterization of lung mechanics in various conditions like infections and allergic disease. The cotton rat is susceptible to several respiratory viruses, such as RSV and HMPV, and is considered an excellent small animal model for RSV research [31, 32]. In order to characterize the pathophysiology of lung infection, we set out to establish sensitive pulmonary function measurement techniques. Our results provide baseline data for lung physiology studies in the cotton rat. We found that in contrast to mice [26, 40, 42, 43], cotton rats were highly sensitive to ketamine, and thus accurate dosing of ketamine based on weight as well as a quiet, low stress environment were required. A technical challenge was the sensitivity of a vagal response to slight manipulation of the peritracheal vagal nerve during tracheotomy.

Our data indicate differences in measurements between the FV-M2 and FX3 flexivent systems, a difference that has also been observed by other groups [48]. One study found that there was no difference in precision or accuracy in resistance between the models; however, the FX system resulted in more accurate compliance measurements [48]. Therefore, the difference in significance in the parameters measured in 4DPI RSV infected female cotton rats between the different instruments may have been partly attributed due to their varying configuration.

Another difficulty in assessing the effect of RSV infection on lung function, is the question of how many groups should be included in the analysis [9, 12, 16, 18, 19, 26, 41, 49, 50]. Whereas small differences in lung function are statistically significant in pairwise comparisons, they are not sufficient to be detected at a significant level in multi group comparisons. In agreement with our data, several studies in mice utilizing forced oscillation technique have also found no significant differences after infection with RSV A2 [12, 16, 26]. Histologically, inflammation associated with RSV peaked 5 days post-infection in the cotton rat lungs, and inflammation was mild with predominately lymphocytic peribronchiolar cuffs as is consistent with previous studies [32]. The mild inflammation associated with RSV is also consistent with the lack of clinical signs and weight loss, and lack of perturbations in the lung function measurements. In contrast to mice, where a two-fold increase in mucus production [16] has been reported, no difference in mucus production was found after RSV infection. The only significant difference was the increase in pulmonary edema at 2 days post-infection. However, these studies did record higher baseline airway resistance in uninfected mice, as well as higher peak airway resistance values in uninfected mice, RSV infected mice, and mice sensitized with an allergen (ovalbumin) possibly due to the smaller airway diameters in mice [12, 16, 18, 40, 42, 43, 51, 52]. HDM sensitized cotton rats had significantly higher histologic inflammatory scores with a distinct eosinophilic component as observed previously [36], as well as inflammatory infiltrates at all locations (peribronchiole, perivascular, alveolar spaces and septae) in contrast to the predominantly peribronchiolar infiltrates of RSV infected cotton rats. The more severe inflammation associated with HDM sensitization was also associated with perturbations in lung function. There was a significant difference in lung mechanics after HDM sensitization. These alterations in pulmonary function correlate with the higher inflammatory scores, suggesting that the severity of respiratory dysfunction is related to inflammation.

In summary, the effect of RSV infection in the cotton rat has been evaluated using state of the art technology. Consistent with the low level of inflammation and mucus production seen in RSV infected cotton rats, disturbances of lung function measured were not significantly different from uninfected cotton rats. Our data indicate, however, that lung function analysis in the cotton rat is valuable for other respiratory diseases, such as asthma or other viral infections that induce more severe inflammation.

Supporting information

S1 Fig. Mucus production in female uninfected cotton rats and cotton rats 5 days post-infection with RSV A2.

Quantification of PAS and Alcian blue positive (mucus) staining in bronchioles was performed using a semi-quantitative mucus scoring system. The mean and standard deviations are represented (n = 4/ group). There was no significant difference between groups (unpaired student T test, p value > 0.05).

(TIF)

S2 Fig. Pulmonary edema after RSV A2 infection in female cotton rats.

The lung wet: dry weigh ratios in uninfected cotton rats and cotton rats 2, 4 or 6 days post-RSV infection. Mean wet: dry weight ratios and standard deviations are represented. There is no significant difference when all groups were compared to one another by One-Way ANOVA, p > 0.05; uninfected (n = 3), 2DPI RSV (n = 2), 4DPI RSV (n = 4), 6 DPI RSV (n = 4).

(TIF)

S3 Fig. Comparison of male versus female bronchiolar widths.

The diameter of an average of 43 small airways (bronchioles) per uninfected animal were measured microscopically. The mean and standard deviation for each group are represented. One-way ANOVA, p>0.05 (n = 4).

(TIF)

S4 Fig. Lung mechanics curves in uninfected cotton rats and 2, 4, 6 and 28 days post-RSV A2 infection female cotton rats.

The mean and standard deviation for each group are represented. Figure a represents total airway resistance (R). Figure b represents tissue damping (G). Figure c represents dynamic pulmonary compliance (C). Uninfected (n ranges 7–6), 2DPI RSV (n = 3), 4DPI RSV (n ranges 7–6), 6DPI RSV (n = 5), 28DPI RSV (n ranges 6–5).

(TIF)

S5 Fig. Comparison of baseline compliance between uninfected and 4 days post-RSV infected cotton rats.

The mean and standard deviation for each group are represented. Both female and male cotton rats were presented in each group. Baseline pulmonary compliance was measured using forced oscillation technique. Asterisks indicate p< 0.05 by an unpaired two-tailed Student T-test.

(TIF)

S6 Fig. Effect of system on lung function measurements.

Pulmonary function was measured in female cotton rats using the FV-M2 (old) and FX3 (new) flexivent system in uninfected and 4 days post-infection (DPI) with RSV in female cotton rats. The mean and standard deviation for each group are represented. Figures a-c represent total airway resistance (R). Figures d-f represent tissue damping (G). Figures g-i represent dynamic pulmonary compliance (C). Figures a, d, and g represent the lung mechanic curves for R, G, and C. Figures b, e, and h represent the baseline measurements for R, G, and C. Figures c, f, and i represent the measurements obtained at 50mg/mL methacholine dosage for R, G, and C. Bars indicate p< 0.05 by One-way ANOVA; uninfected old system (n ranges 7–6), 4DPI RSV old system RSV (n ranges7-6), uninfected new system (n = 5), 4DPI RSV new system (n = 5).

(TIF)

S7 Fig. Lung mechanics curves in uninfected cotton rats and HDM-sensitized female cotton rats.

The mean and standard deviation for each group are represented. A) Measurement of total airway resistance (R). B) Measurement of issue damping (G). C) Measurement of dynamic pulmonary compliance (C). Uninfected (n ranges 7–6), HDM (n = 4).

(TIF)

S1 Table. Semi-quantitative histologic inflammatory scoring system.

(DOCX)

S2 Table. Semi-quantitative histologic mucus scoring system.

(DOCX)

S3 Table. Collar sensor clip pulse oximetry measurements.

(DOCX)

S4 Table. Thigh sensor clip pulse oximetry measurements.

(DOCX)

S5 Table. Arterial blood gas measurements.

(DOCX)

Acknowledgments

The authors would like to thank Dr. La Perle and the Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University for the help with making and scanning the histology slides for this project. The authors would also like to thank Tim Vojt for his help with formatting the images for publication.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

M.E.M. was funded through the Genetech Fellowship under grant number GRT00044407 from Genentech (https://www.gene.com/). O.E.H. and S.N. were funded through grant number P01AI112524 from the National Institute of Health National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/). L.E.R., L. J. and I.C.D. were funded through grant number HL137090 from National Institutes of Health/National Heart Lung & Blood Institute (https://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatric pulmonology. 2017;52(4):556–69. Epub 2016/10/16. 10.1002/ppul.23570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wennergren G, Kristjansson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. The European respiratory journal. 2001;18(6):1044–58. Epub 2002/02/07. 10.1183/09031936.01.00254101 . [DOI] [PubMed] [Google Scholar]
  • 3.Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2007;20(1):108–19. Epub 2006/12/05. 10.1038/modpathol.3800725 . [DOI] [PubMed] [Google Scholar]
  • 4.Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus. American journal of diseases of children (1960). 1979;133(8):798–802. Epub 1979/08/01. 10.1001/archpedi.1979.02130080038006 . [DOI] [PubMed] [Google Scholar]
  • 5.Zomer-Kooijker K, Uiterwaal CS, van der Gugten AC, Wilbrink B, Bont LJ, van der Ent CK. Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants. The European respiratory journal. 2014;44(3):666–74. Epub 2014/07/06. 10.1183/09031936.00009314 . [DOI] [PubMed] [Google Scholar]
  • 6.Broughton S, Sylvester KP, Fox G, Zuckerman M, Smith M, Milner AD, et al. Lung function in prematurely born infants after viral lower respiratory tract infections. The Pediatric infectious disease journal. 2007;26(11):1019–24. Epub 2007/11/07. 10.1097/INF.0b013e318126bbb9 . [DOI] [PubMed] [Google Scholar]
  • 7.Drysdale SB, Wilson T, Alcazar M, Broughton S, Zuckerman M, Smith M, et al. Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax. 2011;66(6):468–73. Epub 2011/03/31. 10.1136/thx.2010.148023 . [DOI] [PubMed] [Google Scholar]
  • 8.Boyoglu-Barnum S, Gaston KA, Todd SO, Boyoglu C, Chirkova T, Barnum TR, et al. A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. Journal of virology. 2013;87(20):10955–67. Epub 2013/07/26. 10.1128/JVI.01164-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. Journal of virology. 2011;85(12):5782–93. Epub 2011/04/08. 10.1128/JVI.01693-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mejias A, Chavez-Bueno S, Rios AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, et al. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrobial agents and chemotherapy. 2004;48(5):1811–22. Epub 2004/04/24. 10.1128/aac.48.5.1811-1822.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jiang XB, Huang M, Cui XF, Zhu Y, Yin KS, Yao K. Respiratory syncytial virus infection differentiates airway dysfunction in the central and peripheral airways in OVA-sensitized mice. Experimental lung research. 2012;38(9–10):453–62. Epub 2012/09/12. 10.3109/01902148.2012.723240 . [DOI] [PubMed] [Google Scholar]
  • 12.Song W, Yu Z, Doran SF, Ambalavanan N, Steele C, Garantziotis S, et al. Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness. American journal of physiology Lung cellular and molecular physiology. 2015;309(3):L205–10. Epub 2015/06/14. 10.1152/ajplung.00159.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Saravia J, You D, Shrestha B, Jaligama S, Siefker D, Lee GI, et al. Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLoS pathogens. 2015;11(10):e1005217 Epub 2015/10/17. 10.1371/journal.ppat.1005217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Han J, Takeda K, Wang M, Zeng W, Jia Y, Shiraishi Y, et al. Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection. American journal of respiratory cell and molecular biology. 2014;51(1):143–54. Epub 2014/02/14. 10.1165/rcmb.2013-0360OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mori H, Parker NS, Rodrigues D, Hulland K, Chappell D, Hincks JS, et al. Differences in respiratory syncytial virus and influenza infection in a house-dust-mite-induced asthma mouse model: consequences for steroid sensitivity. Clinical science (London, England: 1979). 2013;125(12):565–74. Epub 2013/06/25. 10.1042/cs20130098 . [DOI] [PubMed] [Google Scholar]
  • 16.Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. Journal of virology. 2009;83(9):4185–94. Epub 2009/02/13. 10.1128/JVI.01853-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. Journal of immunology (Baltimore, Md: 1950). 2005;175(3):1876–83. Epub 2005/07/22. 10.4049/jimmunol.175.3.1876 . [DOI] [PubMed] [Google Scholar]
  • 18.Collins RA, Gualano RC, Zosky GR, Atkins CL, Turner DJ, Colasurdo GN, et al. Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice. Respiratory research. 2005;6:142 Epub 2005/12/06. 10.1186/1465-9921-6-142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Makela MJ, Kanehiro A, Dakhama A, Borish L, Joetham A, Tripp R, et al. The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. American journal of respiratory and critical care medicine. 2002;165(6):824–31. Epub 2002/03/19. 10.1164/ajrccm.165.6.2105062 . [DOI] [PubMed] [Google Scholar]
  • 20.Peebles RS Jr., Sheller JR, Collins RD, Jarzecka AK, Mitchell DB, Parker RA, et al. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. Journal of medical virology. 2001;63(2):178–88. Epub 2001/02/15. . [PubMed] [Google Scholar]
  • 21.Peebles RS Jr., Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, et al. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. The Journal of infectious diseases. 2001;184(11):1374–9. Epub 2001/12/26. 10.1086/324429 . [DOI] [PubMed] [Google Scholar]
  • 22.Peebles RS Jr., Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. Journal of medical virology. 1999;57(2):186–92. Epub 1999/01/19. . [DOI] [PubMed] [Google Scholar]
  • 23.Chi XY, Jiang SJ, Wang J, Wang JP. Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection. Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand. 2011;29(2):176–80. Epub 2011/10/11. . [PubMed] [Google Scholar]
  • 24.Schwarze J, Schauer U. Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein. Thorax. 2004;59(6):517–21. Epub 2004/06/01. 10.1136/thx.2003.017343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Peebles RS Jr., Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. The Journal of infectious diseases. 2000;182(3):671–7. Epub 2000/08/19. 10.1086/315783 . [DOI] [PubMed] [Google Scholar]
  • 26.Traylor ZP, Yu EN, Davis IC. Respiratory syncytial virus induces airway insensitivity to beta-agonists in BALB/c mice. American journal of physiology Lung cellular and molecular physiology. 2010;298(3):L437–45. Epub 2009/12/08. 10.1152/ajplung.00363.2009 . [DOI] [PubMed] [Google Scholar]
  • 27.Zysman-Colman Z, Lands LC. Whole Body Plethysmography: Practical Considerations. Paediatric respiratory reviews. 2016;19:39–41. Epub 2016/01/23. 10.1016/j.prrv.2015.11.008 . [DOI] [PubMed] [Google Scholar]
  • 28.Urbankowski T, Przybylowski T. Methods of airway resistance assessment. Pneumonologia i alergologia polska. 2016;84(2):134–41. Epub 2016/05/31. 10.5603/PiAP.2016.0014 . [DOI] [PubMed] [Google Scholar]
  • 29.Lundblad LK, Irvin CG, Hantos Z, Sly P, Mitzner W, Bates JH. Penh is not a measure of airway resistance! The European respiratory journal. 2007;30(4):805 Epub 2007/10/02. 10.1183/09031936.00091307 . [DOI] [PubMed] [Google Scholar]
  • 30.Domachowske JB, Bonville CA, Rosenberg HF. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. The Pediatric infectious disease journal. 2004;23(11 Suppl):S228–34. Epub 2004/12/04. 10.1097/01.inf.0000144672.81955.a4 . [DOI] [PubMed] [Google Scholar]
  • 31.Amelia RW, Martin LM, Sujin L. Animal Models of Respiratory Syncytial Virus Pathogenesis and Vaccine Development: Opportunities and Future Directions: INTECH Open Access Publisher; 2011. [Google Scholar]
  • 32.Boukhvalova MS, Blanco JC. The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection. Current topics in microbiology and immunology. 2013;372:347–58. Epub 2013/12/24. 10.1007/978-3-642-38919-1_17 . [DOI] [PubMed] [Google Scholar]
  • 33.Skylogianni E, Douros K, Anthracopoulos MB, Fouzas S. The Forced Oscillation Technique in Paediatric Respiratory Practice. Paediatric respiratory reviews. 2016;18:46–51. Epub 2016/01/19. 10.1016/j.prrv.2015.11.001 . [DOI] [PubMed] [Google Scholar]
  • 34.Parameswaran H, Suki B. Assessing Structure-Function Relations in Mice Using the Forced Oscillation Technique and Quantitative Histology. Methods in molecular biology (Clifton, NJ). 2017;1639:77–91. Epub 2017/07/29. 10.1007/978-1-4939-7163-3_8 . [DOI] [PubMed] [Google Scholar]
  • 35.Aeffner F, Bolon B, Davis IC. Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements. Toxicologic pathology. 2015;43(8):1074–92. Epub 2015/08/25. 10.1177/0192623315598399 . [DOI] [PubMed] [Google Scholar]
  • 36.Green MG, Petroff N, La Perle KMD, Niewiesk S. Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection. Comparative medicine. 2018;68(1):31–40. Epub 2018/02/21. [PMC free article] [PubMed] [Google Scholar]
  • 37.Kittel B, Ruehl-Fehlert C, Morawietz G, Klapwijk J, Elwell MR, Lenz B, et al. Revised guides for organ sampling and trimming in rats and mice—Part 2. A joint publication of the RITA and NACAD groups. Experimental and toxicologic pathology: official journal of the Gesellschaft fur Toxikologische Pathologie. 2004;55(6):413–31. Epub 2004/09/24. 10.1078/0940-2993-00349 . [DOI] [PubMed] [Google Scholar]
  • 38.Hofer CC, Woods PS, Davis IC. Infection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype. American journal of physiology Lung cellular and molecular physiology. 2015;308(7):L628–38. Epub 2015/01/18. 10.1152/ajplung.00373.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wu Y, Ma J, Woods PS, Chesarino NM, Liu C, Lee LJ, et al. Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexes. Journal of controlled release: official journal of the Controlled Release Society. 2015;203:140–9. Epub 2015/02/18. 10.1016/j.jconrel.2015.02.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Aeffner F, Traylor ZP, Yu EN, Davis IC. Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. American journal of physiology Lung cellular and molecular physiology. 2011;301(1):L99–l109. Epub 2011/04/12. 10.1152/ajplung.00398.2010 . [DOI] [PubMed] [Google Scholar]
  • 41.Boyoglu-Barnum S, Todd SO, Chirkova T, Barnum TR, Gaston KA, Haynes LM, et al. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology. 2015;483:117–25. Epub 2015/05/13. 10.1016/j.virol.2015.02.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.McGovern TK, Robichaud A, Fereydoonzad L, Schuessler TF, Martin JG. Evaluation of respiratory system mechanics in mice using the forced oscillation technique. Journal of visualized experiments: JoVE. 2013;(75):e50172 Epub 2013/05/29. 10.3791/50172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Aeffner F, Davis IC. Respiratory syncytial virus reverses airway hyperresponsiveness to methacholine in ovalbumin-sensitized mice. PloS one. 2012;7(10):e46660 Epub 2012/10/12. 10.1371/journal.pone.0046660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Card JW, Carey MA, Bradbury JA, DeGraff LM, Morgan DL, Moorman MP, et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. Journal of immunology (Baltimore, Md: 1950). 2006;177(1):621–30. Epub 2006/06/21. 10.4049/jimmunol.177.1.621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. The Journal of infectious diseases. 2014;209 Suppl 3:S120–6. Epub 2014/06/27. 10.1093/infdis/jiu232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wethington D, Harder O, Uppulury K, Stewart WCL, Chen P, King T, et al. Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats. Journal of the Royal Society, Interface. 2019;16(160):20190389 Epub 2019/11/28. 10.1098/rsif.2019.0389 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Current topics in microbiology and immunology. 2013;372:39–57. Epub 2013/12/24. 10.1007/978-3-642-38919-1_2 . [DOI] [PubMed] [Google Scholar]
  • 48.Robichaud A, Fereydoonzad L, Urovitch IB, Brunet JD. Comparative study of three flexiVent system configurations using mechanical test loads. Experimental lung research. 2015;41(2):84–92. Epub 2014/11/15. 10.3109/01902148.2014.971921 . [DOI] [PubMed] [Google Scholar]
  • 49.Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, Anderson LJ. The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. Journal of virology. 2003;77(11):6580–4. Epub 2003/05/14. 10.1128/jvi.77.11.6580-6584.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Makela MJ, Tripp R, Dakhama A, Park JW, Ikemura T, Joetham A, et al. Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. The Journal of allergy and clinical immunology. 2003;112(5):861–9. Epub 2003/11/12. 10.1016/s0091-6749(03)02020-7 . [DOI] [PubMed] [Google Scholar]
  • 51.Shalaby KH, Gold LG, Schuessler TF, Martin JG, Robichaud A. Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness. Respiratory research. 2010;11:82 Epub 2010/06/23. 10.1186/1465-9921-11-82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Reddy AT, Lakshmi SP, Reddy RC. Murine model of allergen induced asthma. Journal of visualized experiments: JoVE. 2012;(63):e3771 Epub 2012/05/24. 10.3791/3771 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Steven M Varga

3 Jun 2020

PONE-D-20-10846

Pulmonary function analysis in cotton rats after respiratory syncytial virus infection

PLOS ONE

Dear Dr. Martinez,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers raised important questions that need to be addressed concerning the choice of viral strains and the timing of the measurements for some of the lung function parameters.  In addition, several clarifications were requested regarding the experimental design and the description of the methods. Please respond to each of the criticisms raised by the reviewers. In some cases it may be necessary to perform additional experiments in order to fully address a reviewer concern.

Please submit your revised manuscript by Jul 18 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Steven M. Varga, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

3. Thank you for stating the following in the Financial Disclosure section:

'M.E.M. was funded through the Genetech Fellowship under grant number GRT00044407 from Genentech (https://www.gene.com/). O.E.H. and S.N. were funded through grant number P01AI112524 from the National Institute of Health National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/). L.E.R., L. J. and I.C.D. were funded through grant number HL137090 from National Institutes of Health/National Heart Lung & Blood Institute (https://www.nhlbi.nih.gov/).

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.'

We note that you received funding from a commercial source: Genentech

a. Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc.

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

b. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Martinez et al describes an interesting work on forced oscillation technique in cotton rats infected with RSV or sensitized with HDM. This work is important, as application of this technique to cotton rats is novel and multiple parameters need to be established for the model. The use of HDM sensitization to achieve this task is justified and appeared to be highly successful. The application of technique in RSV-infected cotton rats, however, yielded some conflicting results. It was reported by one study that RSV infection in female cotton rats led to increased airway reactivity on day 4 pi (Fig.4a), while the data apparently could not be reproduced by another study (Fig.5a). Since this observation could be one of the most important conclusions of this work, a question arises as to whether suboptimal conditions were chosen for RSV infection. RSV infectious dose of 105 TCID50 per animal was chosen, yet this dose is associated with minimal inflammation in the cotton rat lungs, as was confirmed by data shown in Fig. 1 of this manuscript. Increasing RSV challenge 5- to 10-fold from the amount chosen by the authors of this manuscript is known to significantly increase pulmonary inflammation in cotton rats, and could be a more appropriate model for assessing airway reactivity in the model. Additional, it is not clear why RSV-line 19F was chosen for some studies along with the RSV A2 (e.g., mucus production), but not other studies where RSV A2 strain was used alone (e.g., edema, airway hyperreacticity). It appears that inclusion of both strains in all types of assessment, and using both viruses at a higher challenge dose could have increased informative potential of this work as it applies to RSV infection. Additionally, the selection of some other aspects of methodology is also not clear. For example, mucus production was assessed on d8 post-infection, with the date selection based on previous murine studies, as indicated by the authors. Yet, dynamics of RSV infection in cotton rats and mice is different, therefore d8 assessment could be suboptimal for mucus production assessment in RSV-infected cotton rats. Moreover, the sex differences were addressed in some studies (e.g., airway hyperreactivity), and not others (e.g., mucus production, edema), with justification for this choice not being clear. Overall, this work addresses an important issue and shows application of a new technique in cotton rats, demonstrating difference as they apply to HDM sensitization. The conditions for RSV infection, however, may need to be expanded to more accurately assess pulmonary function in the model.

Misc. comments:

-Fig.1 legend: description does not appear to accurately correspond to specific panels.

-There is no description of horizontal bars

-BAL WBS count is shown, but no method is described in the Materials and Methods.

-Inflation of the entire cotton rat lung (for the animal of indicated age) with 1 ml 4% paraformaldehyde can result in under inflation. Please check the amount used and reported (p.5, line 103).

-Table on p.6-8 may be redundant considering the reference cited and could be removed.

-It is not clear if all of the experiments were repeated and if so, how reproducible the results have been.

Reviewer #2: In this manuscript, the authors measured lung inflammation/mucus, arterial blood gas, and lung physiology in the cotton rat model of respiratory syncytial virus infection. They found that RSV did not elicit substantial lung/airway inflammation at days 4/5 after infection, did not significantly change arterial blood gas, and only caused airways responsiveness to methacholine challenge in female mice. In contrast, cotton rats that had been sensitized and challenged to house dust mite had significant increases in airway inflammation, mucus and airways responsiveness. The manuscript is well written, and the results presented are clear and convincing. Given that this is the first report of lung mechanics in the cotton rat in the setting RSV-induced disease, the results are useful in regard to vaccine and other approaches to treatment in future studies. It would have also been interesting to see if RSV infection during the course of allergic airway inflammation, such as in the dust mite model the authors use, would have caused exacerbated airways responsiveness as is seen in humans with asthma or in the mouse model of combined allergic and RSV disease.

Major points

Line 217 - There are concerns with the timing of the measurements of endpoints. For instance, as the authors point out, RSV line 19 elicited airway mucus and methacholine-induced airway responsiveness in mice, yet this occurred at day 8 after infection, after the appearance of the adaptive immune response and the activation of ILC2. Therefore, the absence of these findings in this report may have been related to measurements at times when IL-13 was not present, rather than the cotton rat not having either mucus or airways responsiveness. The lack of an extended time course of measurement of endpoints at the time of the peak of the adaptive immune response should be noted in the discussion. Of course, it is certainly possible that RSV line 19 or other strains that cause airway mucus expression and airways responsiveness in mice might not cause such findings in the cotton rat, but it is curious why the authors performed the measurements at the times that they did.

Line 219 - It is unclear why the authors assessed BAL cell counts on day 4/5 before the adaptive immune response has had time to develop. This likely reflects the low level of airway inflammation that they see at this time point. Openshaw published that innate cells such as NK cells and neutrophils are present within the first 4 days after infection, but then CD8+ and CD4+ cells are more abundant at days 7 through 9 after infection (Clin Mircobiol Rev 18:541-555, 2005)

Minor point

Line 141 - The authors state that the cotton rats were anesthetized for FlexiVent measurements and that the blood was obtained from carotid artery for measurement of arterial blood gas. The timing of the blood sampling relative to the pulmonary function measurements is not stated and is very important. If the methacholine challenge was performed prior to ABG measurement, then the bronchoconstriction from that procedure may have lowered the ABG measurement as methacholine causes airway obstruction. If on the other hand, the ABG was performed first, then the blood loss may have confounded the methacholine challenge measurement. I am not recommending that the experiments be performed again but want to make sure it is clear when the ABG measurement was made relative to the methacholine challenge. Also, the possibility of confounding the measurements based on the timing should be mentioned in the discussion.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Stokes Peebles

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 10;15(8):e0237404. doi: 10.1371/journal.pone.0237404.r002

Author response to Decision Letter 0


7 Jul 2020

Responses to reviewers:

Reviewer #1:

1. It was reported by one study that RSV infection in female cotton rats led to increased airway reactivity on day 4 pi (Fig.4a), while the data apparently could not be reproduced by another study (Fig.5a). Since this observation could be one of the most important conclusions of this work, a question arises as to whether suboptimal conditions were chosen for RSV infection. RSV infectious dose of 105 TCID50 per animal was chosen, yet this dose is associated with minimal inflammation in the cotton rat lungs, as was confirmed by data shown in Fig. 1 of this manuscript. Increasing RSV challenge 5- to 10-fold from the amount chosen by the authors of this manuscript is known to significantly increase pulmonary inflammation in cotton rats, and could be a more appropriate model for assessing airway reactivity in the model.

The difference between groups found in Figure 4a reflects the fact that a small number of groups was compared to each other, and therefore the statistical comparison detected a small difference. In Figure 5a, due to the comparison of a larger number of groups the small differences were not statistically significant. We concluded that the small difference in lung function was not reproducible nor clinically relevant which admittedly might be a conservative interpretation of the data.

In our hands, an inoculation dose of 105 TCID50 RSV is physiologically most relevant. We found that virus replication in lung tissue increased from 101 to 105 TCID50 [1] but did not further increase after inoculation of 106 TCID50 and inflammation as determined by BALF was also not significantly increased with a higher does [2]. A concern with the investigation of lung function after infection in a rodent model with a superphysiological dose is the induction of an artificially high level of inflammation due to a large amount of virus particles rather than virus replication. An example of this was published by us using a superphysiologic dose of measles virus (107 pfu instead of 105 pfu) [3].

2. I it is not clear why RSV-line 19F was chosen for some studies along with the RSV A2 (e.g., mucus production), but not other studies where RSV A2 strain was used alone (e.g., edema, airway hyperreacticity). It appears that inclusion of both strains in all types of assessment, and using both viruses at a higher challenge dose could have increased informative potential of this work as it applies to RSV infection.

In cotton rats, RSV line 19F replicates and induces inflammation like RSV A2 (the commonly used virus strain in cotton rats). Previous studies in mice have found a difference in mucus production after infection with RSV line 19F vs RSV A2 [4, 5]. The determination of the ability of RSV line 19F to potentially induce mucus production in cotton rats was the only rational for using it (added in line 281-282).

3. The selection of some other aspects of methodology is also not clear. For example, mucus production was assessed on d8 post-infection, with the date selection based on previous murine studies, as indicated by the authors. Yet, dynamics of RSV infection in cotton rats and mice is different, therefore d8 assessment could be suboptimal for mucus production assessment in RSV-infected cotton rats.

In total we assessed the effect of RSV infection in cotton rats by histology at day 2, 4, 5, 6, 8, and 28 post-infection. Some studies have demonstrated that mucus production is related to neutrophilic enzymes [6-8] which correlate with peak inflammation. For this reason we have also assessed mucus production 5 days post-RSV infection using a semi-quantitative scoring scheme (see added S4 Table) but could not detect any increase in mucus production in cotton rat lungs.

4. The sex differences were addressed in some studies (e.g., airway hyperreactivity), and not others (e.g., mucus production, edema), with justification for this choice not being clear.

We used both sexes for all measurements, and performed a gender-specific analysis. However, this is only reported in the figures if there is a gender specific difference. This information has been added to M&M (added line- 225-227). In addition, supplemental figures S2 and S5 have been added to expand upon the gender differences or lack thereof in cotton rats after RSV infection.

Misc. comments:

-Fig.1 legend: description does not appear to accurately correspond to specific panels.

Changes have been made.

-There is no description of horizontal bars

In the figure legends, it is stated that the bars indicate a significant difference (p<0.05).

-BAL WBS count is shown, but no method is described in the Materials and Methods.

This has been added at line 131-138.

-Inflation of the entire cotton rat lung (for the animal of indicated age) with 1 ml 4% paraformaldehyde can result in under inflation. Please check the amount used and reported (p.5, line 103).

The cotton rat lung is relatively small compared to its body volume. We have tested different inoculation doses and found that greater than 1mL fluid induces histological artifacts that could be misconstrued as edema.

-Table on p.6-8 may be redundant considering the reference cited and could be removed.

The table has been moved to supplemental materials (S1 Table).

-It is not clear if all of the experiments were repeated and if so, how reproducible the results have been.

Individual experiments were repeated 3 to 5 times. Aggregate animal numbers were statistically analyzed (added in M&M, line 224)

Reviewer #2

Major points

1. Line 217 - There are concerns with the timing of the measurements of endpoints. For instance, as the authors point out, RSV line 19 elicited airway mucus and methacholine-induced airway responsiveness in mice, yet this occurred at day 8 after infection, after the appearance of the adaptive immune response and the activation of ILC2. Therefore, the absence of these findings in this report may have been related to measurements at times when IL-13 was not present, rather than the cotton rat not having either mucus or airways responsiveness. The lack of an extended time course of measurement of endpoints at the time of the peak of the adaptive immune response should be noted in the discussion. Of course, it is certainly possible that RSV line 19 or other strains that cause airway mucus expression and airways responsiveness in mice might not cause such findings in the cotton rat, but it is curious why the authors performed the measurements at the times that they did.

The goal of our study was to determine the effects of acute RSV infection on lung function in cotton rats. This was based on the fact that many studies seem to correlate measurable lung dysfunction in laboratory rodents with increased inflammation and damage, such as models of acute respiratory distress syndrome [9, 10].In the cotton rat, adaptive immune responses correlate well with peak virus titers in lung tissue at day 4 and 6 [11, 12]. We did test later time points (day 28) based on previous publications demonstrating persistent inflammation thus providing ample time for an adaptive immune response to be mounted [13]. Many of the previous studies that suggest later time points for evaluating lung function were performed in mice and typically used whole body plethysmography or other less sensitive and accurate methods than forced oscillation technique [5, 14].

2. Line 219 - It is unclear why the authors assessed BAL cell counts on day 4/5 before the adaptive immune response has had time to develop. This likely reflects the low level of airway inflammation that they see at this time point. Openshaw published that innate cells such as NK cells and neutrophils are present within the first 4 days after infection, but then CD8+ and CD4+ cells are more abundant at days 7 through 9 after infection (Clin Microbiol Rev 18:541-555, 2005)

In the cotton rat, adaptive immune responses correlate well with peak virus titers in lung tissue at day 4 and 6 [11]. We assessed inflammation at days 4 and 5 via histology and/or BAL. Consistent with finding by others [12, 13] peak inflammation correlates with peak RSV replication and decreases from day 6 onward.

Minor point

3. Line 141 - The authors state that the cotton rats were anesthetized for FlexiVent measurements and that the blood was obtained from carotid artery for measurement of arterial blood gas. The timing of the blood sampling relative to the pulmonary function measurements is not stated and is very important. If the methacholine challenge was performed prior to ABG measurement, then the bronchoconstriction from that procedure may have lowered the ABG measurement as methacholine causes airway obstruction. If on the other hand, the ABG was performed first, then the blood loss may have confounded the methacholine challenge measurement. I am not recommending that the experiments be performed again but want to make sure it is clear when the ABG measurement was made relative to the methacholine challenge. Also, the possibility of confounding the measurements based on the timing should be mentioned in the discussion.

We used separate groups of animals for the flexivent and the ABG measurements as both are terminal procedures.

References:

1. Wethington D, Harder O, Uppulury K, Stewart WCL, Chen P, King T, et al. Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats. Journal of the Royal Society, Interface. 2019;16(160):20190389. Epub 2019/11/28. doi: 10.1098/rsif.2019.0389. PubMed PMID: 31771450.

2. Green MG, Petroff N, La Perle KMD, Niewiesk S. Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection. Comparative medicine. 2018;68(1):31-40. Epub 2018/02/21. PubMed PMID: 29460719; PubMed Central PMCID: PMCPMC5824137.

3. P. NSaG. Development of neutralizing antibodies correlates with resolution of interstitial pneumonia after measles virus infection in cotton rats. Journal of Experimental Animal Science. 1999;(40):201-10.

4. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. Journal of virology. 2009;83(9):4185-94. Epub 2009/02/13. doi: 10.1128/jvi.01853-08. PubMed PMID: 19211758; PubMed Central PMCID: PMCPMC2668460.

5. Boyoglu-Barnum S, Gaston KA, Todd SO, Boyoglu C, Chirkova T, Barnum TR, et al. A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. Journal of virology. 2013;87(20):10955-67. Epub 2013/07/26. doi: 10.1128/jvi.01164-13. PubMed PMID: 23885067; PubMed Central PMCID: PMCPmc3807296.

6. Boukhvalova MS, Prince GA, Blanco JC. The cotton rat model of respiratory viral infections. Biologicals : journal of the International Association of Biological Standardization. 2009;37(3):152-9. Epub 2009/04/28. doi: 10.1016/j.biologicals.2009.02.017. PubMed PMID: 19394861; PubMed Central PMCID: PMCPMC2882635.

7. Cortjens B, de Boer OJ, de Jong R, Antonis AF, Sabogal Pineros YS, Lutter R, et al. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease. The Journal of pathology. 2016;238(3):401-11. Epub 2015/10/16. doi: 10.1002/path.4660. PubMed PMID: 26468056.

8. Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, et al. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. Journal of virology. 2013;87(18):10070-82. Epub 2013/07/12. doi: 10.1128/jvi.01347-13. PubMed PMID: 23843644; PubMed Central PMCID: PMCPmc3753991.

9. Song W, Yu Z, Doran SF, Ambalavanan N, Steele C, Garantziotis S, et al. Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness. American journal of physiology Lung cellular and molecular physiology. 2015;309(3):L205-10. Epub 2015/06/14. doi: 10.1152/ajplung.00159.2015. PubMed PMID: 26071553; PubMed Central PMCID: PMCPmc4525118.

10. Aeffner F, Bolon B, Davis IC. Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements. Toxicologic pathology. 2015;43(8):1074-92. Epub 2015/08/25. doi: 10.1177/0192623315598399. PubMed PMID: 26296628.

11. Rajagopala SV, Singh H, Patel MC, Wang W, Tan Y, Shilts MH, et al. Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection. Scientific reports. 2018;8(1):11318. Epub 2018/07/29. doi: 10.1038/s41598-018-29374-x. PubMed PMID: 30054492; PubMed Central PMCID: PMCPMC6063970 is a for profit contract research organization that uses the cotton rat model for pre-clinical studies.

12. Prince GA, Jenson AB, Horswood RL, Camargo E, Chanock RM. The pathogenesis of respiratory syncytial virus infection in cotton rats. The American journal of pathology. 1978;93(3):771-91. Epub 1978/12/01. PubMed PMID: 362946; PubMed Central PMCID: PMCPMC2018360.

13. Grieves JL, Yin Z, Durbin RK, Durbin JE. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus). Comparative medicine. 2015;65(4):315-26. Epub 2015/08/28. PubMed PMID: 26310461; PubMed Central PMCID: PMCPMC4549677.

14. Wu YH, Lai AC, Chi PY, Thio CL, Chen WY, Tsai CH, et al. Pulmonary IL-33 orchestrates innate immune cells to mediate RSV-evoked airway hyperreactivity and eosinophilia. Allergy. 2019. Epub 2019/10/18. doi: 10.1111/all.14091. PubMed PMID: 31622507.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Steven M Varga

27 Jul 2020

Pulmonary function analysis in cotton rats after respiratory syncytial virus infection

PONE-D-20-10846R1

Dear Dr. Martinez,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Steven M. Varga, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All comments have been adequately addressed. No additional comments/concerns are raised. The manuscript is recommended for acceptance for publication.

Reviewer #2: The authors have appropriately responded to my critiques and I believe that the manuscript is now ready for publication in PLoS One.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Steven M Varga

30 Jul 2020

PONE-D-20-10846R1

Pulmonary function analysis in cotton rats after respiratory syncytial virus infection

Dear Dr. Martinez:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Steven M. Varga

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Mucus production in female uninfected cotton rats and cotton rats 5 days post-infection with RSV A2.

    Quantification of PAS and Alcian blue positive (mucus) staining in bronchioles was performed using a semi-quantitative mucus scoring system. The mean and standard deviations are represented (n = 4/ group). There was no significant difference between groups (unpaired student T test, p value > 0.05).

    (TIF)

    S2 Fig. Pulmonary edema after RSV A2 infection in female cotton rats.

    The lung wet: dry weigh ratios in uninfected cotton rats and cotton rats 2, 4 or 6 days post-RSV infection. Mean wet: dry weight ratios and standard deviations are represented. There is no significant difference when all groups were compared to one another by One-Way ANOVA, p > 0.05; uninfected (n = 3), 2DPI RSV (n = 2), 4DPI RSV (n = 4), 6 DPI RSV (n = 4).

    (TIF)

    S3 Fig. Comparison of male versus female bronchiolar widths.

    The diameter of an average of 43 small airways (bronchioles) per uninfected animal were measured microscopically. The mean and standard deviation for each group are represented. One-way ANOVA, p>0.05 (n = 4).

    (TIF)

    S4 Fig. Lung mechanics curves in uninfected cotton rats and 2, 4, 6 and 28 days post-RSV A2 infection female cotton rats.

    The mean and standard deviation for each group are represented. Figure a represents total airway resistance (R). Figure b represents tissue damping (G). Figure c represents dynamic pulmonary compliance (C). Uninfected (n ranges 7–6), 2DPI RSV (n = 3), 4DPI RSV (n ranges 7–6), 6DPI RSV (n = 5), 28DPI RSV (n ranges 6–5).

    (TIF)

    S5 Fig. Comparison of baseline compliance between uninfected and 4 days post-RSV infected cotton rats.

    The mean and standard deviation for each group are represented. Both female and male cotton rats were presented in each group. Baseline pulmonary compliance was measured using forced oscillation technique. Asterisks indicate p< 0.05 by an unpaired two-tailed Student T-test.

    (TIF)

    S6 Fig. Effect of system on lung function measurements.

    Pulmonary function was measured in female cotton rats using the FV-M2 (old) and FX3 (new) flexivent system in uninfected and 4 days post-infection (DPI) with RSV in female cotton rats. The mean and standard deviation for each group are represented. Figures a-c represent total airway resistance (R). Figures d-f represent tissue damping (G). Figures g-i represent dynamic pulmonary compliance (C). Figures a, d, and g represent the lung mechanic curves for R, G, and C. Figures b, e, and h represent the baseline measurements for R, G, and C. Figures c, f, and i represent the measurements obtained at 50mg/mL methacholine dosage for R, G, and C. Bars indicate p< 0.05 by One-way ANOVA; uninfected old system (n ranges 7–6), 4DPI RSV old system RSV (n ranges7-6), uninfected new system (n = 5), 4DPI RSV new system (n = 5).

    (TIF)

    S7 Fig. Lung mechanics curves in uninfected cotton rats and HDM-sensitized female cotton rats.

    The mean and standard deviation for each group are represented. A) Measurement of total airway resistance (R). B) Measurement of issue damping (G). C) Measurement of dynamic pulmonary compliance (C). Uninfected (n ranges 7–6), HDM (n = 4).

    (TIF)

    S1 Table. Semi-quantitative histologic inflammatory scoring system.

    (DOCX)

    S2 Table. Semi-quantitative histologic mucus scoring system.

    (DOCX)

    S3 Table. Collar sensor clip pulse oximetry measurements.

    (DOCX)

    S4 Table. Thigh sensor clip pulse oximetry measurements.

    (DOCX)

    S5 Table. Arterial blood gas measurements.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES